O

OptiNose
D

OPTN

0.70030
USD
0.03
(4.12%)
Market Closed
Volume
7,069
EPS
0
Div Yield
0
P/E
-2
Market Cap
105,589,001
OverviewSignalsIdeasNews
Related Instruments
    AMGN
    2.78
    (0.84%)
    335.22 USD
    A
    ASLN
    -0.09150
    (-13.23%)
    0.60000 USD
    A
    AUPH
    -0.28000
    (-4.76%)
    5.60000 USD
    E
    EYPT
    -0.75000
    (-7.58%)
    9.14000 USD
    GSK
    0.865
    (2.23%)
    39.650 USD
    MRK
    0.680
    (0.60%)
    113.800 USD
    PFE
    0.115
    (0.38%)
    30.650 USD
    REGN
    13.14
    (1.22%)
    1,091.19 USD
    V
    VHC
    -0.03000
    (-0.46%)
    6.48000 USD
News

Title: OptiNose

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
OptiNose Inc is a specialty pharmaceutical company that focuses on the development and commercialization of products for patients treated by ear, nose, and throat, and allergy specialists. Its product includes XHANCE (fluticasone propionate) nasal spray, 93 micrograms, a therapeutic utilizing its proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. The XHANCE is able to deliver medication to the primary site of inflammation high and deep in the nasal passages in regions not adequately reached by intranasal steroids.